title: [A chronic gingival hypertrophy].
authors.forename: Dalila
authors.initials: D
authors.lastname: Mrabet
authors.forename: Zeineb
authors.initials: Z
authors.lastname: Alaya
authors.forename: Samia Khouja
authors.initials: SK
authors.lastname: Bahri
authors.forename: Habiba
authors.initials: H
authors.lastname: Mizouni
authors.forename: Ines
authors.initials: I
authors.lastname: Chelly
authors.forename: Héla
authors.initials: H
authors.lastname: Sahli
authors.forename: Elhème
authors.initials: E
authors.lastname: Cheour
authors.forename: Mohamed
authors.initials: M
authors.lastname: Elleuch
authors.forename: Slim
authors.initials: S
authors.lastname: Haouet
authors.forename: Badia
authors.initials: B
authors.lastname: Jemmali
authors.forename: Nihel
authors.initials: N
authors.lastname: Meddeb
authors.forename: Slaheddine
authors.initials: S
authors.lastname: Sellami
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D002908:Chronic Disease; D005260:Female; D005881:Gingiva / Q000473:pathology; D005886:Gingival Hypertrophy / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D006984:Hypertrophy; D012460:Sulfasalazine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D018501:Antirheumatic Agents; D012460:Sulfasalazine